Screening for head and neck tumors in patients with esophageal squamous cell carcinoma and vice versa: a nationwide survey among medical specialists

Autor: Laurelle van Tilburg, Sophie A. van den Ban, Steffi E.M. van de Ven, Aniel Sewnaik, Marco J. Bruno, Manon C.W. Spaander, Robert J. Baatenburg de Jong, Arjun D. Koch

Publikováno v: Endoscopy International Open, Vol 10, Iss 09, Pp E1268-E1274 (2022)

Background and study aims Retrospectively, minimally 5% of patients with esophageal squamous cell carcinoma (ESCC) and 11 % with head and neck squamous cell carcinoma (HNSCC) in Western countries developed a second primary tumor (SPT). SPT screening

Externí odkaz: https://doaj.org/article/f8e832a664cb450f98de07d48e0f4b5c

Analysis of metastases rates during follow-up after endoscopic resection of early 'high-risk' esophageal adenocarcinoma

Autor: Esther A. Nieuwenhuis, Sanne N. van Munster, Sybren L. Meijer, Lodewijk A.A. Brosens, Marnix Jansen, Bas L.A. M. Weusten, Lorenza Alvarez Herrero, Alaa Alkhalaf, Ed Schenk, Erik J. Schoon, Wouter L. Curvers, Arjun D. Koch, Steffi E.M. van de Ven, Eva P.D. Verheij, Wouter B. Nagengast, Jessie Westerhof, Martin H.M. G. Houben, Thjon Tang, Jacques J.G. H.M. Bergman, Roos E. Pouw, A. Karrenbeld, A. Ooms, C. Huysentruyt, F. ten Kate, F. Moll, G. Kats-Ugurlu, I. van Lijnschoten, J. van de Laan, J. Offerhaus, K. Biermann, K. Seldenrijk, L. Brosens, S. Meijer, M. Doukas

Publikováno v: Nieuwenhuis, E A, van Munster, S N, Meijer, S L, Brosens, L A A, Jansen, M, Weusten, B L A M, Alvarez Herrero, L, Alkhalaf, A, Schenk, E, Schoon, E J, Curvers, W L, Koch, A D, van de Ven, S E M, Verheij, E P D, Nagengast, W B, Westerhof, J, Houben, M H M G, Tang, T, Bergman, J J G H M, Pouw, R E, Dutch Barrett Expert Centers, Karrenbeld, A, Ooms, A, Huysentruyt, C, ten Kate, F, Moll, F, Kats-Ugurlu, G, van Lijnschoten, I, van de Laan, J, Offerhaus, J, Biermann, K, Seldenrijk, K, Brosens, L, Meijer, S & Doukas, M 2022, ' Analysis of metastases rates during follow-up after endoscopic resection of early “high-risk” esophageal adenocarcinoma ', Gastrointestinal Endoscopy, vol. 96, no. 2, pp. 237-247.e3 . https://doi.org/10.1016/j.gie.2022.03.005
Gastrointestinal Endoscopy, 96(2), 237-247.e3. Mosby Inc.
Gastrointestinal endoscopy, 96(2), 237-247.e3. Mosby Inc.
Gastrointestinal endoscopy, 96(2), 237-247.e3. MOSBY-ELSEVIER
Gastrointestinal Endoscopy, 96(2), 237-247.E3. MOSBY-ELSEVIER

Background and Aims: After endoscopic resection (ER) of early esophageal adenocarcinoma (EAC), the optimal management of patients with high-risk histologic features for lymph node metastases (ie, submucosal invasion, poor differentiation grade, or ly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39db53474d22bbb3e51f589e66af9a3a
https://research.vumc.nl/en/publications/4ec5822f-10e1-441c-835d-575043cbf08b